Programme

Wednesday, 23 May

16:00 – 18:00 Registration
18:00 – 21:00 Get-together party

Fagernäs Mansion, Kuopio

Thursday, 24 May

7:45 Registration
8:20 – 8:30 Welcome
SSHNO President, Professor Antti Mäkitie, Helsinki, FINLAND and Professor Heikki Löppönen, Kuopio, FINLAND
8:30 – 10:00 SESSION 1 / IMMUNOTHERAPY IN HEAD AND NECK

Chair Docent Heikki Irjala, Turku, FINLAND

8:30 – 9:15 THE BASIS OF IMMUNOTHERAPY IN ONCOLOGY

Sirpa Jalkanen, Academician, Turku, FINLAND

9:15 – 10:00 IMMUNOTHERAPY IN HEAD AND NECK CANCER
Joseph Sacco, MD, PhD, Liverpool, UK
10:00 – 10:30 COFFEE / TEA, EXHIBITION
10:30 – 12:00 SESSION 2 / FREE PAPERS (7 minutes per presentation)
Chairs Professor Lalle Hammerstedt-Nordenvall, Stockholm, SWEDEN and Docent Petri Koivunen, Oulu, FINLAND

Prognostic value of pretreatment FDG-PET/CT parameters in patients with oral and oropharyngeal squamous cell cancer, Constantina Christou
CIP2A and Oct4 in head and neck squamous cell carcinoma, Johannes Routila
De-escalation of post-treatment surveillance in oropharyngeal cancer, Taru Ilmarinen
What can proinflammatory cytokines in serum after cancer treatment tell us? Thorsteinn Astradsson
Excessive fluid administration increases the risk of MACCE in Head and Neck Oncologic Surgery, Eeva Haapio
Prognostic factors, treatment, and survival, for patients with sinonasal mucosal melanoma compared with other sinonasal cancers, Anna Hafström
Treatment outcome and timing of disease recurrence in T1 glottic cancer, Pihla Pakkanen
Causes for delays before specialist consultation in head and neck cancer, Timo Atula
Patients with tongue cancer can be distinguished from healthy controls by label-free serum proteomics, Amy Dickinson
Epstein-Barr virus and human papillomaviruses are favourable prognostic factors in Finnish nasopharyngeal carcinoma – a nationwide study, Miia Ruuskanen
Early mortality after treatment for Head and Neck cancer – Who and Why? Charbél Talani
A Large, Yet Asymptomatic Glottic Tumour, Richmond Quan Qing Lim
12:00 – 13:15 LUNCH, EXHIBITION
12:00 – 13:15 Separate satellite lunch session:
Bristol-Myers Squibb Company Satellite Lunch Symposium
Immuno-Oncology in Head and Neck Cancer, Patient Case Discussions with Dr Joseph Sacco, UK
Venue: Scandic Kuopio, Minna 1+2 (IOFI18NP00256-01) *Doctors only due to local laws and regulations
13:15 – 14:45 SESSION 3 / HEAD AND NECK RECONSTRUCTION
Chairs Professor Oddveig Rikardsen, Tromsö, NORGE and Docent Ilpo Kinnunen, Turku, FINLAND
13:15 – 13:45 HELSINKI EXPERIENCE

Patrik Lassus, Docent, Plastic Reconstructive Surgeon, Helsinki, FINLAND

13:45 – 14:15 STOCKHOLM EXPERIENCE

Martin Halle, MD, PhD, Plastic and Reconstructive Surgeon, Stockholm, SWEDEN

14:15 – 14:45 BIRMINGHAM EXPERIENCE

Paul Pracy, ENT – Consultant Surgeon, Birmingham, UK

14:45 – 15:15 COFFEE / TEA, EXHIBITION
15:15 – 16:00 SESSION 4 / SPECIAL LECTURE 1
Chair Professor Cai Crau, Aarhus, Denmark
DELINEATION OF THE PRIMARY TUMOUR CLINICAL TARGET VOLUMES IN HEAD AND NECK SQUAMOUS CELL CARCINOMA: INTERNATIONAL CONSENSUS GUIDELINES
Vincent Gregoire, MD, PhD, Hon FRCR (UK and IE), Professor, Dept. of Radiation Oncology, St-Luc University Hospital, Brussels, BELGIUM
16:00 – 16:45 SESSION 5 / SPECIAL LECTURE 2
Chair Professor Heikki Löppönen, Kuopio, FINLAND
CANCER GENE THERAPY: PAST; PRESENT AND FUTURE
Seppo Ylä-Herttuala, Academy Professor, Kuopio, FINLAND
16:45 – 17:15 GENERAL ASSEMBLY OF SSHNO
20:00 – 23:00 DINNER, SCANDIC KUOPIO

Friday, 25 May

7:45 – 9:15 CyberKnife®-TOUR
Visit to Kuopio University Radiohospital – CyberKnife®-DEMO
9:15 – 9:45 SESSION 6 / BNCT IN HEAD AND NECK ONCOLOGY
Chair Docent Matti Pukkila, Kuopio, FINLAND
THE RETURN OF BORON NEUTRON CAPTURE THERAPY (BNCT);

HELSINKI EXPERIENCE
Tiina Seppälä, PhD, Helsinki, FINLAND

9:45 – 10:15 COFFEE / TEA, EXHIBITION
10:15 – 11:45 SESSION 7 / PALLIATIVE ASPECTS
Chair Professor Göran Laurell, Uppsala, SWEDEN
10:15 – 10:20 DO WE NEED PALLIATIVE AND SUPPORTIVE CARE IN HEAD AND NECK CANCER PATIENTS?

Matti Pukkila, Docent, Kuopio, FINLAND

10:20 – 10.30 THE NORDIC PALLIATIVE CARE HEAD AND NECK CANCER SURVEY

Lovisa Farnebo, Docent, Linköping, SWEDEN

10:30 – 11:05 ADDRESSING SOME SPECIAL PROBLEMS IN PALLIATIVE CARE: NAUSEA, FATIGUE, MALAISE AND CACHEXIA

Reino Pöyhiä, Docent, Helsinki, FINLAND

11:05 – 11:45 COMMUNICATION WITH SERIOUSLY ILL PATIENT – BREAKING THE BAD NEWS

Päivi Hietanen, Docent, Helsinki, FINLAND

12:00 – 13:15 LUNCH, EXHIBITION
13:15 – 15:00 SESSION 8 / NUTRITION IN HEAD AND NECK CANCER PATIENTS

Chair Professor Ursula Schwab, Kuopio, FINLAND

13:15 – 13:55 NUTRITIONAL STATUS AND SUPPORT IN HEAD AND NECK CANCER PATIENTS

Marie Lundberg, MD, PhD and Helena Orell, MSc, Dietitian, Helsinki, FINLAND

13:55 – 14:40 PREVENTION OF DISEASE-RELATED MALNUTRITION – DEVELOPMENT OF TAILORED APPLICATION

Mari Mohn Paulsen, PhD Candidate, Registered Dietitian, Oslo, NORWAY

14:40 – 15:00 NEW EFFECTIVE TRAINING METHOD FOR DYSPHAGIA IN HEAD AND NECK CANCER PATIENTS UNDERGOING RADIOTHERAPY

Irene Wessel, Docent, Copenhagen, Denmark

15:00 – 16:00 SESSION 9 / NORDIC LARYNGEAL CANCER STUDY
Jens Overgaard, Professor, Århus, Denmark
15:00 – 15:10 DENMARK
15:10 – 15:20 SWEDEN
15:20 – 15:30 NORWAY
15:30 – 15:40 ICELAND
15:40 – 15:50 FINLAND
15:50 – 16:00 SUMMARY – FUTURE PLANS
16:00 – 16:20 CLOSURE AND ADJOURN
SHNO President, Professor Antti Mäkitie, Helsinki, Finland